|
Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance
RECRUITINGN/ASponsored by University Hospital Tuebingen
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital Tuebingen
Started2026-09-24
Est. completion2029-03-31
Eligibility
Age18 Years – 40 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07730645
Summary
The study aims to show that treatment with LtAPD works better than a sham treatment or simply monitoring the condition closely without active treatment ("active surveillance"), in achieving complete healing of a tissue abnormality on the cervix called CIN 2, after 6 months. This will be confirmed by examining tissue samples under a microscope (histopathological examination).
Eligibility
Age: 18 Years – 40 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Female sex * Age 18 - 40 years at the time of signing the informed consent * Histologically confirmed CIN 2 * Full visibility of the entire transformation zone (Type 1 or Type 2) and entire lesion in colposcopy * Ability to understand the nature of the clinical investigation and voluntarily signs the informed consent document prior to any study-related procedures Exclusion Criteria: * Histologically confirmed CIN other than CIN 2, or indication of (micro-) invasive cervical disease * CIN lesions extending to the vaginal vault or suspicion of endocervical disease * Current pregnancy or planned pregnancy within the next 6 months * Presence of severe local inflammation or active infection * Presence of a severe cardiovascular, neurological, psychiatric, endocrine, or hematological disease, immunocompromised condition or malignant tumor of any origin, as judged by the investigator * Participation in an interfering clinical study, as judged by the investigator
Conditions4
CIN2CancerCervical Intraepithelial Neoplasia Grade 2Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital Tuebingen
Started2026-09-24
Est. completion2029-03-31
Eligibility
Age18 Years – 40 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07730645